Squar Milner Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,957
Closed -$524K 26
2020
Q2
$524K Buy
1,957
+115
+6% +$34.6K 0.3% 92
2020
Q1
$582K Buy
1,842
+442
+32% +$134K 0.35% 59
2019
Q4
$415K Sell
1,400
-564
-29% -$156K 0.21% 107
2019
Q3
$557K Buy
1,964
+473
+32% +$110K 0.28% 92
2019
Q2
$349K Buy
1,491
+243
+19% +$56.1K 0.24% 98
2019
Q1
$295K Sell
1,248
-126
-9% -$39.7K 0.22% 113
2018
Q4
$413K Hold
1,374
0.4% 58
2018
Q3
$485K Buy
1,374
+177
+15% +$60.9K 0.44% 52
2018
Q2
$347K Hold
1,197
0.31% 85
2018
Q1
$328K Sell
1,197
-34
-3% -$10.6K 0.41% 80
2017
Q4
$441K Buy
+1,231
New +$395K 0.53% 57

Other funds holding BIIB

Squar Milner Financial Services's BIIB Position: Q3 2020 in Review

Squar Milner Financial Services sold out of Biogen (BIIB) in Q3 2020, closing a stake of 1,957 shares — an estimated $524K sold.

Squar Milner Financial Services first reported a position in BIIB in Q4 2017 and held it in 11 quarters. The position peaked at $582K in Q1 2020. 1,052 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Squar Milner Financial Services reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 1,957 Biogen shares in Q3 2020, an estimated $524K.
  • Squar Milner Financial Services first reported a position in Biogen in Q4 2017 and held it in 11 quarters.
  • Squar Milner Financial Services's Biogen position peaked at $582K in Q1 2020.
  • 1,052 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.